Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
2017;159(Suppl 5):715
1 Introduction Lenvatinib is a small-molecule tyrosine kinase inhibitor (TKI) that targets multiple receptors, including vascular endothelial growth factor receptors (VEGFRs) 13, fibroblast growth factor receptors (FGFRs) 14, and platelet-derived growth factor receptor (PDGFR) and (Matsui et al., 2008)
brown adipose tissue: 300 g)
After 6 h, cell viability was measured with CellTiter-Blue , following the instructions of the manufacturer (Promega)
Prices from 52.00 In stock
US$ 21.24
US$ 20.12
US$ 27.56
US$ 26.35
US$ 29.29
US$ 22.89
US$ 22.41
